← Leaderboards
Rachel Greene
Vanderbilt University
$160,422
Attributed
$160,422
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $55.8K · FY2008–10$100K$75K$50K$25K$0
'08
'09
'10
Funding mix
By agency
NIH$160,422 · 1
By mechanism
F32$160,422 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Sekhar Raja Konjeti$867,359
- Eugene M. Oltz$20,457,685
- Nancy J Olsen$6,548,556
- Michael L. Freeman$14,431,534
- Dennis E Hallahan$13,109,924
Others in their field
Top investigators on “Vascular Endothelial Growth Factor Receptor-2”
- Bjorn R Olsen · Beth Israel Deaconess Medical Center$9,402,463
- Shahin Rafii · Weill Medical College Of Cornell Univ$6,581,211
- Michael Simons · Yale University$6,209,820
- Aleksander S. Popel · Johns Hopkins University$5,625,203
- Nilanjana Maulik · University Of Connecticut Sch Of Med/Dnt$4,894,273
- William C Aird · Harvard University (Medical School)$4,861,541
Research focus
Vascular Endothelial Growth Factor Receptor-2NanoparticleDistressDissociationAngiogenesisBaseAdenovirus VectorCell MotilityBiodistributionBiologicalAreaBlood VesselsBypassCancer TherapyCarrying CapacitiesBinding (Molecular Function)Cell ProliferationBiodegradable PolymerClinical MedicineComplexCostCost EfficientBloodDirect Application
Grant awards (4)
Therapeutic VEGFR-2 Silencing via Targeted Nanoparticles$55,790
F32 · FY2010 · CA · contact PI
Therapeutic VEGFR-2 Silencing via Targeted Nanoparticles$53,354
F32 · FY2009 · CA · contact PI
Therapeutic VEGFR-2 Silencing via Targeted Nanoparticles$29,610
F32 · FY2008 · CA · contact PI
Therapeutic VEGFR-2 Silencing via Targeted Nanoparticles$21,668
F32 · FY2008 · CA · contact PI